Table 1.
TRPM4 modulators
| Molecule | EC50/IC50 (μM) | References |
|---|---|---|
| Activator / Potentiator | ||
| Intracellular Ca2+ | 0.3–1000 | Colquhoun, 1981; Yellen, 1982; Launay, 2002; Nilius, 2003; Nilius, 2004; Nilius, 2005; Ullrich, 2005; Yarishkin, 2008; Sala-Rabanal, 2012; Amarouch, 2013; Yamaguchi, 2014; Winkler, 2017; Autzen, 2018; Hu, 2024 |
| Intracellular Co2+ with Ca2+ | 107 | Yamaguchi, 2014 |
| Intracellular Mn2+ with Ca2+ | ND | Yamaguchi, 2014 |
| Intracellular Ni2+ with Ca2+ | ND | Yamaguchi, 2014 |
| PIP2 with Ca2+ | 4–42.2 | Zhang, 2005; Nilius, 2006; Yamaguchi, 2014; Guo, 2017 |
| BTP2 | 0.008 | Takezawa, 2006 |
| Decavanadate with Ca2+ | 1.9 | Nilius, 2004; Winkler, 2017; Hu, 2024 |
| Mg2ATP | ND | Zhang, 2005; Nilius, 2006; Guo, 2017 |
| Inhibitor | ||
| Adenosine | 630 | Sturgess, 1986; Nilius, 2004 |
| AMP | 19 | Sturgess, 1986; Nilius, 2004 |
| ADP | 2.2 | Sturgess, 1986; Nilius, 2004 |
| ATP | 0.8–2.3 | Sturgess, 1986; Nilius, 2004; Guo, 2017; Arullampalam 2021; Hu, 2024 |
| AMP-PNP | 19 | Thorn, 1992; Nilius, 2004 |
| Spermine | 61 | Nilius, 2004 |
| Flufenamic acid | 2.8–5.5 | Korbmacher, 1995; Guinamard, 2006; Demion, 2007; Morita, 2007 |
| Clotrimazole | ND | Ullrich, 2005 |
| Glibenclamide | ND | Guinamard, 2006; Demion, 2007; Sala-Rabanal, 2012 |
| 9-phenanthrol | 10–30 | Grand, 2008; Gonzales, 2010 |
| CBA (Compound 5) | 0.7–1.8 | Ozhathil, 2018 |
| NBA (Compound 6) | 0.1–0.2 | Ozhathil, 2018; Arullampalam, 2021 |
ND, not determined.